The agreement will see the two companies expand current oligonucleotide technologies

New data now reveals significant increases in the blood glucose time-in-range compared to baseline, following VX-880 dosage

The multidisciplinary Zurich research team Liver4Life has succeeded in doing something during a treatment attempt that had never […]

The liver has a unique ability to regenerate after damage. However, it was unknown whether this ability decreases […]

It’s been 12 years since the UK government set out their vision for patients having greater involvement in […]

A private cancer treatment provider, which last year opened a community diagnostic hub in partnership with an NHS […]

Many scientists breathed a sigh of relief when the UK finally signed a Trade and Cooperation Agreement with […]

Enhertu reduced the risk of disease progression or death compared to chemotherapy in certain patients with metastatic breast […]

New facility opens on the Cambridge Research Park offering pharmaceutical development services